EBUNOLA AYOOLA-YUSSUF: Open Payments
NPI 1497938849 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,734 in 83 payments from 12 companies in 2025. Trend: 2023 $578 · 2024 $938 · 2025 $1,734
Food & beverage: $1,734
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $338 |
| Otsuka America Pharmaceutical, Inc. | 15 | $278 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $267 |
| ABBVIE INC. | 16 | $235 |
| Axsome Therapeutics, Inc. | 8 | $163 |
| Lundbeck LLC | 6 | $156 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Alkermes, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $38 |
Products named: REXULTI, CAPLYTA, VRAYLAR, FANAPT, Auvelity, HETLIOZ, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
